BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 13, 2012
View Archived Issues
New human cellular models of Alzheimer's disease developed
Read More
Scientists link new genes to Baraitser-Winter syndrome
Read More
In vitro results show potency of novel bispecific HIV-1-neutralizing antibody
Read More
OPKO Health attains global license to novel Parkinson's disease candidate
Read More
Anthera Pharmaceuticals stops VISTA-16 study
Read More
Further data reported on add-on boceprevir therapy in HCV/HIV-coinfected patients
Read More
Cellceutix files pre-IND submission for candidate psoriasis drug
Read More
Intrepid to conduct phase II trial of candidate acne treatment
Read More
MediGene announces additional approvals of topical drug for genital warts
Read More
Watson Pharmaceuticals launches new phase III trial
Read More
BrainStorm Cell Therapeutics plans stem cell trial in MS
Read More
Aradigm obtains clearance for phase III Pulmaquin study
Read More
Shionogi identifies new P2X3 and P2X2/3 receptor antagonists
Read More
New PI3K inhibitors developed
Read More
Novel potential neutropenia therapies developed
Read More
Merck & Co. announces new vaccines
Read More
Astellas Pharma discloses new inhibitors of IL-2 production and PI3Kdelta
Read More
Medivir launches two new phase III TMC-485 studies
Read More
Allon Therapeutics advances preclinical work in Parkinson's disease
Read More
Amorfix announces new technology acquisition
Read More
Immunovaccine and Weill Cornell Medical College join to develop anticocaine vaccine
Read More
Tranzyme Pharma and Norgine report topline data on ulimorelin
Read More
Reviva Pharmaceuticals kicks off enrollment in phase II RP-5063 trial
Read More
DNDi launches phase I trial of drug for sleeping sickness
Read More
Phase II results trigger milestone payment to NicOx
Read More
